Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Gastric MALT Lymphoma
NCT03680586Phase 1Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2019
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in gastric mucosa-associated lymphoid tissue lymphoma, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Complete gastric response at 1 year. Started Feb 2019; status: active, not recruiting.
02
Conditions
gastric mucosa-associated lymphoid tissue lymphoma
Beyond the preview
Go deeper on NCT03680586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680586.